Works by Zhang, Ruixing


Results: 36
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Iparomlimab (QL1604) in patients with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) unresectable or metastatic solid tumors: a pivotal, single-arm, multicenter, phase II trial.

    Published in:
    Journal of Hematology & Oncology, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13045-024-01627-5
    By:
    • Bi, Feng;
    • Dong, Jian;
    • Jin, Chuan;
    • Niu, Zuoxing;
    • Yang, Wenhui;
    • He, Yifu;
    • Yu, Dajun;
    • Sun, Meili;
    • Wang, Teng;
    • Yin, Xianli;
    • Zhang, Ruixing;
    • Chen, Kehe;
    • Wang, Keming;
    • Wang, Zhiwu;
    • Li, Wei;
    • Zhang, Zhongtao;
    • Zhang, Hangyu;
    • Guo, Qunyi;
    • Wang, Xin;
    • Han, Lei
    Publication type:
    Article
    36